Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
70.8%Free Cash Flow to Operating Cash Flow
VS
Market
Sector
Industry
History
$ 6.06Close
$ 3.53 - $ 7.6 52-Week Range
Ticker Information
Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQIMMUCELL CORP - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ICCC - FCF/OCF Historical data
| Date | Free Cash Flow | Free Cash Flow to Operating Cash Flow | Net Cash Flow - Operations |
|---|---|---|---|
| 6/30/2025 | $ 1.79M | 70.8% | $ 2.53M |
| 3/31/2025 | $ 793.32K | 52.43% | $ 1.51M |
| 12/31/2024 | $ -103.32K | -28.87% | $ 357.9K |
| 9/30/2024 | $ -708.47K | 0% | $ -362.12K |
| 6/30/2024 | $ -906.61K | 0% | $ -230.54K |
| 3/31/2024 | $ -2.77M | 0% | $ -1.49M |
| 12/31/2023 | $ -6.56M | 0% | $ -4.67M |
| 9/30/2023 | $ -8.55M | 0% | $ -5.25M |
| 6/30/2023 | $ -9.61M | 0% | $ -6M |
| 3/31/2023 | $ -8.79M | 0% | $ -4.94M |
Key Performance Insights, Last 5 Years
- IMMUCELL CORP's latest trailing twelve months (TTM) FCF/OCF stands at -284.53%.
- Over the past 5 years, IMMUCELL CORP's average FCF/OCF has been -181.03%.
- The median FCF/OCF for IMMUCELL CORP during this period was -119.67%
- IMMUCELL CORP reached its highest FCF/OCF over the past 5 years at 70.8%.
- The lowest FCF/OCF recorded by IMMUCELL CORP in the same timeframe -829.48%
IMMUCELL CORP's FCF/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF/OCF Benchmarks
Similar metrics to CF - Operations:
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Free Cash Flow to Operating Cash Flow
[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].FCF / CF - Operations
(=) FCF/OCF FCF/OCF for IMMUCELL CORP is calculated as follows: FCF [ $ -3.17M ] / CF - Operations [ $ 1.11M ]
(=) FCF/OCF [ -284.53% ] ICCC - Free Cash Flow to Operating Cash Flow, Last 5 years
-829.48%
Minimum
Sep 30, 2022
70.8%
Maximum
Jun 30, 2025
-181.03%
Average
-119.67%
Median
FCF/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.44% with a standard deviation of 29.12%.
The following table provides additional summary stats:
FCF/OCF in the Market:
| filtered constituents | 2.51K |
|---|---|
| min | -23% |
| max | 171.58% |
| average | 71.44% |
| median | 80.83% |
| std | 29.12% |